JP2008507543A5 - - Google Patents

Download PDF

Info

Publication number
JP2008507543A5
JP2008507543A5 JP2007522737A JP2007522737A JP2008507543A5 JP 2008507543 A5 JP2008507543 A5 JP 2008507543A5 JP 2007522737 A JP2007522737 A JP 2007522737A JP 2007522737 A JP2007522737 A JP 2007522737A JP 2008507543 A5 JP2008507543 A5 JP 2008507543A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
hydrogen
hydroxy
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007522737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008507543A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/025843 external-priority patent/WO2006012396A1/en
Publication of JP2008507543A publication Critical patent/JP2008507543A/ja
Publication of JP2008507543A5 publication Critical patent/JP2008507543A5/ja
Pending legal-status Critical Current

Links

JP2007522737A 2004-07-22 2005-07-21 抗細菌剤 Pending JP2008507543A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59017404P 2004-07-22 2004-07-22
PCT/US2005/025843 WO2006012396A1 (en) 2004-07-22 2005-07-21 Antibacterial agents

Publications (2)

Publication Number Publication Date
JP2008507543A JP2008507543A (ja) 2008-03-13
JP2008507543A5 true JP2008507543A5 (https=) 2008-09-04

Family

ID=35786535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007522737A Pending JP2008507543A (ja) 2004-07-22 2005-07-21 抗細菌剤

Country Status (4)

Country Link
US (1) US20070270417A1 (https=)
EP (1) EP1778688A1 (https=)
JP (1) JP2008507543A (https=)
WO (1) WO2006012396A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2580621A1 (en) * 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
US7648980B2 (en) 2005-01-25 2010-01-19 Glaxo Group Limited Antibacterial agents
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
EP2007377A4 (en) 2006-04-06 2011-08-17 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
WO2007115947A1 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
CN101454319B (zh) * 2006-05-26 2012-06-27 富山化学工业株式会社 新杂环化合物或其盐及其中间体
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
CN101230058A (zh) * 2007-01-23 2008-07-30 上海恒瑞医药有限公司 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
EA015821B1 (ru) 2007-04-20 2011-12-30 Глэксо Груп Лимитед Трициклические азотсодержащие соединения в качестве антибактериальных агентов
ATE520687T1 (de) * 2007-06-15 2011-09-15 Actelion Pharmaceuticals Ltd 3-amino-6-(1-amino-ethyl)-tetrahydropyranderiva e
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
KR101469306B1 (ko) * 2008-01-23 2014-12-04 장쑤 한서 파마슈티칼 캄파니 리미티드 다이사이클로아자알칸 유도체, 이의 제조 방법 및 의학적 용도
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
US8691865B2 (en) * 2008-11-26 2014-04-08 Abbvie Inc. Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers
PA8850301A1 (es) * 2008-11-26 2010-07-27 Abbott Lab Nuevas octahidrociclopenta[c]pirrol-4-aminas sustituidas como bloqueantes de los canales de calcio
ES2561631T3 (es) 2009-01-15 2016-02-29 Glaxo Group Limited Compuestos de naftiridin-2(1H)-ona útiles como agentes antibacterianos
ES2585806T3 (es) 2009-10-23 2016-10-10 Janssen Pharmaceutica N.V. Octahidropirrolo [3,4-c] pirroles disustituidos como moduladores de receptores de orexina
US8796470B2 (en) 2010-05-25 2014-08-05 Abbvie Inc. Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators
KR102032934B1 (ko) * 2011-12-21 2019-10-16 지앙수 헨그루이 메디슨 컴퍼니 리미티드 피롤 6원 헤테로아릴 고리 유도체, 그의 제조 방법, 및 그의 의약 용도
US8822460B2 (en) 2012-04-06 2014-09-02 Janssen Pharmaceutica Nv Fused cyclopentyl antagonists of CCR2
AU2013290418B2 (en) 2012-07-19 2017-08-03 Chaozhong Cai Octahydro-cyclopentapyrrolyl antagonists of CCR2
CN102838609B (zh) * 2012-08-27 2014-12-24 华东师范大学 一种氮杂双环[3.3.0]辛烷衍生物及其制备方法和应用
WO2015048507A1 (en) 2013-09-26 2015-04-02 Mnemosyne Pharmaceuticals, Inc. Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b
JP6546654B2 (ja) 2014-08-22 2019-07-17 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited 淋菌感染を治療するための三環式含窒素化合物
JO3579B1 (ar) 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
US10828302B2 (en) 2016-03-10 2020-11-10 Janssen Pharmaceutica Nv Methods of treating depression using orexin-2 receptor antagonists
KR20240161147A (ko) 2022-03-14 2024-11-12 슬랩 파마슈티컬스 엘엘씨 다중 사이클릭 화합물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2003243A3 (cs) * 2000-07-26 2003-09-17 Smithkline Beecham P. L. C. Aminopiperidinové chinoliny a jejich azaisosterické analogy s antibakteriální aktivitou

Similar Documents

Publication Publication Date Title
JP2008507543A5 (https=)
JP2008506695A5 (https=)
JP2008505926A5 (https=)
JP2005538125A5 (https=)
JP2009532504A5 (https=)
JP2008505920A5 (https=)
JP2005519922A5 (https=)
JP2005527472A5 (https=)
JP5739662B2 (ja) 5,6−ジヒドロ−1h−ピリジン−2−オン化合物
JP2005504747A5 (https=)
RU2007147413A (ru) Аминопиперидинхинолины и их азаизостерические аналоги с антибактериальной активностью
AR049126A1 (es) Derivados de 5, 6, 7, 8 - tetrahidroimidazo[1,5a]piridina con actividad inhibitoria de la aldosterona sintasa, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento del hiperaldosterismo y del sindrome de cushing.
WO2006046039A3 (en) Tetracyclic indole derivatives as antiviral agents
PE20030431A1 (es) DERIVADOS QUINUCLIDINAS COMO AGONISTAS DEL RECEPTOR NICOTINICO DE LA ACETILCOLINA TIPO a7
AR031556A1 (es) Derivados de 3-(diarilmetilen)-8-azabiciclo[3.2.1] octano y composiciones farmaceuticas que los comprenden
AR048023A1 (es) Cetoamidas con p4 ciclicos como inhibidores de ns3 serina proteasa del virus de hepatitis c
JP2008509222A5 (https=)
JP2005525324A5 (https=)
AR048413A1 (es) Compuestos prolina 3,4- (ciclopentil) - fusionados , como inhibidores de serina proteasa ns3 del virus de la hepatitis c
RU2008128452A (ru) Соединения n-(6-членных арил)-амидов, фармацевтическая композиция с противовирусной активностью на их основе, способ лечения или профилактики вирусной инфекции с их помощью и способ их получения
JP2008526999A5 (https=)
AR083246A1 (es) Composicion que comprende compuestos tetraciclicos
HRP20140151T1 (hr) Derivati spiro-indola za lijeäśenje parazitnih bolesti
AR069772A1 (es) Derivados heterociclicos, una composicion farmaceutica y un juego que los comprenden y su uso en la preparacion de un medicamento para el tratamiento de una infeccion parasitaria.
JP2008508359A5 (https=)